GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
GSK plc American Depositary Shares (Each representing two Ordinary Shares) · Now $49.31
-1.0% in 7d after detection
Post-detection moves
1h
—
1d
-0.5%
3d
+0.6%
7d
-1.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS